| 1 |
protein C
(54 times)
|
Hematology
(18 times)
|
PC (6 times)
SNPs (5 times)
PROS (4 times)
|
1992 A novel homozygous missense mutation in the protein C (PROC) gene causing recurrent venous thrombosis.
|
| 2 |
platinum-resistant ovarian cancer
(32 times)
|
Neoplasms
(26 times)
|
OS (11 times)
PFS (10 times)
ORR (8 times)
|
2010 Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: a Gynecologic Oncology Group study.
|
| 3 |
protein C gene
(20 times)
|
Hematology
(8 times)
|
PC (12 times)
DVT (2 times)
PE (2 times)
|
1988 Assignment of the human protein C gene (PROC) to chromosome region 2q14----q21 by in situ hybridization.
|
| 4 |
procainamide
(6 times)
|
Biochemistry
(3 times)
|
AAD (3 times)
ASOC (2 times)
DMPC (2 times)
|
1990 Lupus-inducing drugs alter the structure of supercoiled circular DNA domains.
|
| 5 |
platinum-resistant recurrent ovarian cancer
(5 times)
|
Neoplasms
(2 times)
|
PFS (2 times)
Bev-Gem (1 time)
CI (1 time)
|
2018 Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis.
|
| 6 |
platinum-resistant epithelial ovarian cancer
(3 times)
|
Neoplasms
(3 times)
|
ORR (2 times)
CI (1 time)
FRalpha (1 time)
|
2001 The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients.
|
| 7 |
predictive receiver operating characteristic
(3 times)
|
Entropy
(2 times)
|
ROC (3 times)
NPV (1 time)
PSEP (1 time)
|
2008 The predictive receiver operating characteristic curve for the joint assessment of the positive and negative predictive values.
|
| 8 |
process category
(3 times)
|
Occupational Health
(1 time)
|
ECETOC (2 times)
ART (1 time)
ESs (1 time)
|
2011 Risk assessment of local dermal effects and skin sensitisation under the EU Chemicals Regulation REACH: a proposal for a qualitative, exposure scenario specific, approach.
|
| 9 |
Palliative Radiation Oncology Consult
(2 times)
|
Therapeutics
(1 time)
|
PRT (2 times)
|
2017 A Palliative Radiation Oncology Consult Service's Impact on Care of Advanced Cancer Patients.
|
| 10 |
puberty, obesity and cardiovascular risk
(2 times)
|
Communicable Diseases
(2 times)
|
BP (1 time)
CIMT (1 time)
DBP (1 time)
|
2020 [Association of blood pressure and left ventricular mass in children from the PROC cohort study].
|
| 11 |
1-propionylcarnitine
(1 time)
|
Pathology
(1 time)
|
HEXC (1 time)
LPC (1 time)
PALC (1 time)
|
1993 [Cellular electrophysiological basis of proarrhythmic and antiarrhythmic effects of ischemia-related lipid metabolites].
|
| 12 |
performed targeted gene sequencing of the PC gene
(1 time)
|
Vascular Diseases
(1 time)
|
EPCR (1 time)
PC (1 time)
VTE (1 time)
|
2013 Targeted gene sequencing identifies variants in the protein C and endothelial protein C receptor genes in patients with unprovoked venous thromboembolism.
|
| 13 |
platinum resistant/refractory ovarian cancer
(1 time)
|
Drug Therapy
(1 time)
|
EP (1 time)
|
2019 Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer.
|
| 14 |
probiotic-supplemented and BLG-sensitized
(1 time)
|
Nutritional Sciences
(1 time)
|
BLG (1 time)
OT (1 time)
OTP (1 time)
|
2012 Low doses of allergen and probiotic supplementation separately or in combination alleviate allergic reactions to cow β-lactoglobulin in mice.
|
| 15 |
procarbazine
(1 time)
|
Neoplasms
(1 time)
|
CPH (1 time)
|
1982 Experimental approach for the search of effective drug combination in cancer chemotherapy.
|
| 16 |
processes
(1 time)
|
|
ES (1 time)
LA (1 time)
PAA (1 time)
|
2022 Impact of Antimicrobial Carcass Washes and Processing Techniques on Quality Attributes of Beef Frankfurters.
|
| 17 |
Protein C, Inactivator Of Coagulation Factors Va And VIIIa
(1 time)
|
Medicine
(1 time)
|
CTA (1 time)
WES (1 time)
|
2022 Compound heterozygous protein C deficiency with pulmonary embolism caused by a novel PROC gene mutation: Case report and literature review.
|
A Search Service for Abbreviation / Long Form